These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8495424)

  • 1. Base transitions are the most frequent genetic changes at P53 in gastric cancer.
    Renault B; van den Broek M; Fodde R; Wijnen J; Pellegata NS; Amadori D; Khan PM; Ranzani GN
    Cancer Res; 1993 Jun; 53(11):2614-7. PubMed ID: 8495424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
    Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
    Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells.
    Matozaki T; Sakamoto C; Suzuki T; Matsuda K; Uchida T; Nakano O; Wada K; Nishisaki H; Konda Y; Nagao M
    Cancer Res; 1992 Aug; 52(16):4335-41. PubMed ID: 1322785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the single strand conformation polymorphism technique and PCR to detect p53 gene mutations in small cell lung cancer.
    Hensel CH; Xiang RH; Sakaguchi AY; Naylor SL
    Oncogene; 1991 Jun; 6(6):1067-71. PubMed ID: 1648702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis.
    Tamura G; Kihana T; Nomura K; Terada M; Sugimura T; Hirohashi S
    Cancer Res; 1991 Jun; 51(11):3056-8. PubMed ID: 2032245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular diagnosis of p53 mutations in gastric carcinoma by touch preparation.
    Ricevuto E; Ficorella C; Fusco C; Cannita K; Tessitore A; Toniato E; Gabriele A; Frati L; Marchetti P; Gulino A; Martinotti S
    Am J Pathol; 1996 Feb; 148(2):405-13. PubMed ID: 8579104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
    Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ
    Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor.
    Thorlacius S; Börresen AL; Eyfjörd JE
    Cancer Res; 1993 Apr; 53(7):1637-41. PubMed ID: 8453635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 mutations in ovarian cancer: a late event?
    Mazars R; Pujol P; Maudelonde T; Jeanteur P; Theillet C
    Oncogene; 1991 Sep; 6(9):1685-90. PubMed ID: 1923532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases.
    Yamada Y; Yoshida T; Hayashi K; Sekiya T; Yokota J; Hirohashi S; Nakatani K; Nakano H; Sugimura T; Terada M
    Cancer Res; 1991 Nov; 51(21):5800-5. PubMed ID: 1933850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
    Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
    Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 gene mutations in medulloblastoma. Immunohistochemistry, gel shift analysis, and sequencing.
    Badiali M; Iolascon A; Loda M; Scheithauer BW; Basso G; Trentini GP; Giangaspero F
    Diagn Mol Pathol; 1993 Mar; 2(1):23-8. PubMed ID: 8287222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
    Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms.
    Yamaguchi K; Sugano K; Fukayama N; Nakashima Y; Saotome K; Yokoyama T; Yokota T; Ohkura H
    Am J Gastroenterol; 1997 Feb; 92(2):307-12. PubMed ID: 9040212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 mutations occur in aggressive breast cancer.
    Mazars R; Spinardi L; BenCheikh M; Simony-Lafontaine J; Jeanteur P; Theillet C
    Cancer Res; 1992 Jul; 52(14):3918-23. PubMed ID: 1617667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas.
    Toguchida J; Yamaguchi T; Ritchie B; Beauchamp RL; Dayton SH; Herrera GE; Yamamuro T; Kotoura Y; Sasaki MS; Little JB
    Cancer Res; 1992 Nov; 52(22):6194-9. PubMed ID: 1423262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas.
    Varley JM; Brammar WJ; Lane DP; Swallow JE; Dolan C; Walker RA
    Oncogene; 1991 Mar; 6(3):413-21. PubMed ID: 2011397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FHIT mutations in human primary gastric cancer.
    Gemma A; Hagiwara K; Ke Y; Burke LM; Khan MA; Nagashima M; Bennett WP; Harris CC
    Cancer Res; 1997 Apr; 57(8):1435-7. PubMed ID: 9108441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.